All Stories

  1. Serum Nutritional Markers as Prognostic Factors for Hepatic and Extrahepatic Carcinogenesis in Japanese Patients with Nonalcoholic Fatty Liver Disease

    Article • Nutrition and Cancer, August 2019, Taylor & Francis

    Dr Hidenori Toyoda, Takashi Kumada

  2. Impact of Branched-Chain Amino Acid Granule Therapy in Patients with Hepatocellular Carcinoma Who Have Normal Albumin Levels and Low Branched-Chain Amino Acid to Tyrosine Ratios

    Article • Nutrition and Cancer, April 2019, Taylor & Francis

    Dr Hidenori Toyoda, Megumi Nakashima, Takashi Kumada

  3. Serum WFA+-M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection

    Article • Liver International, July 2015, Wiley

    Dr Hidenori Toyoda

  4. Postinterferon α-fetoprotein elevation and risk of hepatocellular carcinoma development after sustained virological response: Cause or results?

    Article • Hepatology, August 2014, Wolters Kluwer Health

    Dr Hidenori Toyoda

  5. Changes in highly sensitive alpha‐fetoprotein for the prediction of the outcome in patients with hepatocellular carcinoma after hepatectomy

    Article • Cancer Medicine, March 2014, Wiley

    Dr Hidenori Toyoda